Status:
WITHDRAWN
Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy
Lead Sponsor:
Changhua Christian Hospital
Collaborating Sponsors:
Taipei Medical University Hospital
Dalin Tzu Chi General Hospital
Conditions:
Peptic Ulcer Bleeding
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
The investigators used two different doses of esomeprazole (40 mg IV q.d. and 40 mg IV q6h for three days followed by esomeprazole 40 mg q.d. orally in two groups) after successful endoscopic therapy ...
Detailed Description
A bleeding peptic ulcer remains a serious medical problem with significant morbidity and mortality. Endoscopic therapy significantly reduces further bleeding, surgery, and mortality in patients receiv...
Eligibility Criteria
Inclusion
- patients with peptic ulcer bleeding with active bleeding or nonbleeding visible (initial Hb\<10, shock, or coffee grounds or blood in stomach)
Exclusion
- age \>90y/o
- pregnant woman
- allergic to esomeprazole
- unwilling to enter this study
- bleeding tendency
- severe co-morbid illness, including cancer, hepatic failure, renal failure,
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04407832
Start Date
August 1 2011
End Date
September 1 2013
Last Update
May 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Gastroenterology, TMUH
Taipei, Taiwan, 110